Gabriele Escherich

发表

Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.

Arndt Borkhardt, Christina Peters, A. Borkhardt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.